Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heritage Pharma Holdings Inc. is the global parent company for Heritage Pharmaceuticals Inc. (now operating as Avet Pharmaceuticals), a specialty generic pharmaceutical company. It is a wholly owned subsidiary of Emcure Pharmaceuticals Ltd. and serves as the primary commercial arm for Emcure's products in the United States. The company specializes in the development, manufacturing, and marketing of a broad portfolio of generic and legacy branded pharmaceutical products, including oral solids, liquids, and complex injectables. Its therapeutic focus spans oncology, cardiovascular health, metabolic diseases, anti-infectives, and pain management. With a portfolio of over 150 products, Heritage Pharma Holdings leverages a global supply network to provide affordable and accessible healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heritage Pharma Holdings.